G Medical Innovations Holdings Ltd. Ordinary Shares
GMVD
GMVD was delisted on the 23rd of August, 2023.
14 hedge funds and large institutions have $162K invested in G Medical Innovations Holdings Ltd. Ordinary Shares in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 5 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
0% more funds holding
Funds holding: 14 → 14 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
71% less capital invested
Capital invested by funds: $551K → $162K (-$389K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
S
swisspartners
Vaduz,
Liechtenstein
|
+$71.4K |
| 2 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$43K |
| 3 |
Jane Street
New York
|
+$19.3K |
| 4 |
VF
Virtu Financial
New York
|
+$18.7K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$13.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RP
Regal Partners
Sydney, NSW,
Australia
|
-$322K |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
-$22.7K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$15K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$7K |
| 5 |
Citigroup
New York
|
-$7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
S
1
swisspartners
Vaduz,
Liechtenstein
| $40K | +$71.4K | +4,857 | New |
|
|
2
Macquarie Group
Sydney, NSW 2000,
Australia
| $24K | +$43K | +2,924 | New |
|
|
SSA
3
Schonfeld Strategic Advisors
New York
| $16K | -$22.7K | -1,546 | -45% |
|
4
Goldman Sachs
New York
| $15K | – | – | – |
|
|
VF
5
Virtu Financial
New York
| $15K | +$18.7K | +1,273 | +237% |
|
6
JP Morgan Chase
New York
| $14K | – | – | – |
|
|
TSS
7
Two Sigma Securities
New York
| $11K | +$13.6K | +925 | +192% |
|
|
8
Jane Street
New York
| $11K | +$19.3K | +1,315 | New |
|
9
Geode Capital Management
Boston,
Massachusetts
| $9K | – | – | – |
|
10
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $3K | +$5.42K | +369 | New |
|
|
IA
11
IFG Advisors
St. Louis,
Missouri
| $2K | – | – | – |
|
|
IA
12
IFG Advisory
Atlanta,
Georgia
| $2K | +$4.2K | +286 | New |
|
|
RP
13
Regal Partners
Sydney, NSW,
Australia
| – | -$322K | -15,210 | Closed |
|
|
14
Citadel Advisors
Miami,
Florida
| – | -$15K | -723 | Closed |
|
|
15
Citigroup
New York
| – | -$7K | -343 | Closed |
|
|
16
Bank of America
Charlotte,
North Carolina
| – | -$7K | -324 | Closed |
|
GMVD Hedge Fund Activity: Q3 2022 in Review
14 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in G Medical Innovations Holdings Ltd. Ordinary Shares (GMVD) for Q3 2022, worth a combined $162K — down 71% from $551K a quarter earlier.
Fund positioning in GMVD was balanced in Q3 2022: 5 funds opened new positions, 5 closed out, 2 added to existing stakes and 1 trimmed.
The largest buyer was swisspartners, opening a new position worth an estimated $71.4K. The largest seller was Regal Partners, exiting entirely with an estimated $322K sold.
- 14 institutional investors held G Medical Innovations Holdings Ltd. Ordinary Shares (GMVD) as of Q3 2022, unchanged from Q2 2022.
- Funds reported $162K of G Medical Innovations Holdings Ltd. Ordinary Shares stock for Q3 2022, down 71% quarter-over-quarter.
- 5 funds opened new G Medical Innovations Holdings Ltd. Ordinary Shares positions in Q3 2022 and 5 closed out, a net change of 0 holders.
- The largest G Medical Innovations Holdings Ltd. Ordinary Shares buyer in Q3 2022 was swisspartners, an estimated $71.4K added.
- The largest G Medical Innovations Holdings Ltd. Ordinary Shares seller in Q3 2022 was Regal Partners, an estimated $322K sold.
Based on aggregated 13F filings for Q3 2022.